National Tuberculosis Reference Laboratory
National Tuberculosis Reference Laboratory QYP-2012-16: Per 31 December 2012 the SOP on Feedback and Complaints is revised and authorized. This should include a simple and user-friendly form for submitting feedback See Chapter 4: Feedback, including complaints and other relevant factors.
Tags:
National, Revised, Tuberculosis, National tuberculosis
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Vaccine Handling BCG - World Health Organization
extranet.who.intEnsuring the quality of vaccines at country level: Guidelines for health staff At the higher levels of the cold chain, i.e. at the national (central) and
GOOD DOCUMENTATION AND QUALITY …
extranet.who.intGOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
Principles, Good, Management, Quality, Documentation, Good documentation and quality, Good documentation and quality management principles
6. Process control— introduction to quality control
extranet.who.intLaboratory Quality Management System 73 6-1: Introduction QC for varying methods To avoid confusion, the term "quality control" will be used here to mean use
Introduction, System, Laboratory, Management, Quality, Control, Laboratory quality management system, Introduction to quality control
Guidelines: Saturated fatty acid and trans-fatty acid ...
extranet.who.intthe WHO Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health – participated in the WHO guideline development meetings.
SUMMARY OF PRODUCT CHARACTERISTICS
extranet.who.intThis product is intended for use in children. Nonetheless, safety information is provided with respect to adult health issues such as liver disease, pregnancy and lactation, to allow full access to all
Product, Summary, Characteristics, Summary of product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
extranet.who.intArtesunate 60 mg for injection WHOPAR part 4 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 . SUMMARY OF PRODUCT CHARACTERISTICS
Product, Summary, Characteristics, Summary of product characteristics
Varicella Contraindications - WHO/OMS: Extranet …
extranet.who.intContraindications Varicella vaccines (WHO position paper) In immunocompromised persons, including patients with advanced HIV infection, varicella vaccination is currently contraindicated for fear of
Varicella, Contraindications, Varicella contraindications, Contraindications varicella
Anexo 1 Buenas prácticas de la OMS para …
extranet.who.int2 Consideraciones generales El Comité de Expertos sobre Especificaciones para Productos Farmacéuticos de la OMS adoptó en 1999 las guías tituladas Buenas prácticas para laboratorios nacionales de control farmacéutico de la OMS, que fueron publicadas como Anexo 3 de la Serie de Informes Técnicos de la OMS, No. 902, 2002.
Pneumococcal Contraindications - WHO/OMS: …
extranet.who.intContraindications Pneumococcal vaccines (WHO position paper) There are no absolute contraindications to vaccination with pneumococcal polysaccharide vaccine except for an anaphylactic reaction to the previous
Pneumococcal, Contraindications, Pneumococcal contraindications, Contraindications pneumococcal
Contraindications BCG - WHO/OMS: Extranet Systems
extranet.who.intRubella vaccines (WHO position paper) Rubella vaccination should be avoided in pregnancy because of the theoretical, but never demonstrated, teratogenic risk.
Related documents
NATIONAL STRATEGIC PLAN FOR TUBERCULOSIS …
www.tbcindia.gov.inRevised National Tuberculosis Control Programme NATIONAL STRATEGIC PLAN FOR TUBERCULOSIS ELIMINATION 2017–2025 March 2017 Central TB Division, Directorate General of Health Services, Ministry of Health with Family Welfare, Nirman Bhavan, New Delhi – 110 108
National, Revised, Tuberculosis, Revised national tuberculosis
Revised National Health Policy - Gov
www.moh.gov.bwThe revised National Health Policy: National Health Policy: Towards a Healthier Botswana, December 2011 ... The National Health Policy is the product of several stakeholder consultations which makes it more ... TB Tuberculosis THE Total Health Expenditure TOR Terms of Reference TT2+ Tetanus Toxoid 2+
Health, Policy, National, Revised, Tuberculosis, National health policy, Revised national health policy
Official American Thoracic Society/Centers for Disease ...
www.cdc.gov(ERS) and the US National Tuberculosis Controllers Association (NTCA). This guideline provides recommendations on the clin-ical and public health management of tuberculosis in children and adultsinsettingsinwhich mycobacterial cultures,molecular Received 4 June 2016; accepted 6 June 2016.
Tuberculosis in Nigeria
www.ncdc.gov.ng7 Tuberculosis in Nigeria: Rapid Assessment of Infectious Disease Surveillance and Reporting EXECUTIVE SUMMARY Background A country’s ability to report public health events of potential national and international concern relies on early warning systems founded in national surveillance capacities.
FIELD GUIDANCE – Revised January 28, 2022
www.acf.hhs.govNov 08, 2021 · FIELD GUIDANCE – Revised January 28, 2022 (First issued June 4, 2021, last revised November 8 , 2021) RE: Field Guidance #17 – COVID-19 Vaccination of Unaccompanied Children (UC) in ORR Care . ORR care providers are required to adhere to this guidance for COVID-19 vaccination of unaccompanied children (UC) in ORR care.
Operational Policy Manual - The Global Fund to Fight AIDS ...
www.theglobalfund.orgRevised: - OPN on Risk Management across the Grant Lifecycle 7 March 2018 Issue 2.16 Revised: OPN on Grant Revisions 18 December 2017 Issue 2.15 Revised: - OPN on Access To Funding, Grant-making and Approval 1 November 2017 Issue 2.14 Updated portfolio categorization (list of COE countries) 25 April 2017 Issue 2.13
Policy, Manual, Operational, Revised, Operational policy manual